Comprehensive Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.8K Buy
640
+6
+0.9% +$350 0.03% 171
2025
Q4
$34.2K Buy
634
+7
+1% +$337 0.02% 182
2025
Q3
$28.3K Buy
627
+7
+1% +$327 0.02% 192
2025
Q2
$28.7K Buy
620
+7
+1% +$344 0.02% 178
2025
Q1
$37.4K Buy
613
+5
+0.8% +$291 0.04% 150
2024
Q4
$34.4K Buy
+608
New +$34K 0.03% 176

Other funds holding BMY

Comprehensive Financial Planning's BMY Position: Q1 2026 in Review

Comprehensive Financial Planning increased its Bristol-Myers Squibb (BMY) stake by 0.95% in Q1 2026, buying an estimated $350 and bringing the position to 640 shares worth $38.8K. The position accounts for 0.03% of the portfolio, ranked #171.

Comprehensive Financial Planning first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Comprehensive Financial Planning held 640 shares of Bristol-Myers Squibb worth $38.8K as of Q1 2026.
  • Comprehensive Financial Planning bought 6 Bristol-Myers Squibb shares in Q1 2026, an estimated $350.
  • Bristol-Myers Squibb made up 0.03% of Comprehensive Financial Planning's portfolio in Q1 2026, its #171 holding.
  • Comprehensive Financial Planning first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Comprehensive Financial Planning's 13F filing for Q1 2026, filed 7 Apr 2026.